Log In
Print
BCIQ
Print
Print this Print this
 

mitomycin (Mitosol)

  Manage Alerts
Collapse Summary General Information
Company Mobius Therapeutics LLC
DescriptionSystem used to deliver antifibrotic agents in the eye
Molecular Target
Mechanism of Action 
Therapeutic ModalityMedical Devices
Latest Stage of DevelopmentMarketed
Standard Indication Ophthalmic (unspecified)
Indication DetailsPrevent corneal haze following surface ablation laser keratectomy; Prevent recurrence of pterygium after its surgical excision; Use as an adjunct for ab externo glaucoma surgery
Regulatory Designation

U.S. - Orphan Drug (Prevent corneal haze following surface ablation laser keratectomy)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today